A research team has developed a blood-triggered self-sealing and tissue adhesive hemostatic nanofabric, reported in Nature Communications, offering significant improvements in bleeding control and wound closure.
The nanofabric activates in response to blood components, swiftly sealing and adhering to tissues to reduce blood loss and enhance patient outcomes.
Engineered with biomolecular moieties reactive to blood constituents, the nanofabric halts bleeding promptly and securely anchors to tissues for effective hemostasis.
The material's adhesive properties aid in tissue repair and wound closure, promoting healing and minimizing scar formation.
The nanofabric's design balances porosity and mechanical strength, allowing for blood absorption, breathability, and easy application on various wound shapes.
Its specificity to thrombin activity ensures site-specific functionality, prolongs shelf life, and outperforms standard hemostats in preclinical tests in reducing bleeding times.
The nanofabric's lightweight and flexible nature enables easy storage and rapid deployment in emergency kits, ambulances, and surgical meshes.
Incorporating drug delivery capabilities, the nanofabric could release antibiotics or growth factors to promote healing and infection control.
This innovative hemostatic solution could revolutionize emergency and surgical care, offering vast potential in trauma, childbirth, and accidents.
The nanofabric's adaptability to different tissue types and potential for personalized medicine highlight its future impact on hemostasis and wound care.